Results 51 to 60 of about 155,441 (160)

Frequency of pneumonitis among malnourished autopsied adults [PDF]

open access: yes, 2009
The objective of this study was to investigate whether malnourished autopsied adults would present higher frequency of pneumonitis than non-malnourished ones would. All of the autopsied adults (n = 175; age > 18 years) with complete records, including
Millena Prata Jammal   +3 more
core   +1 more source

Clinical characteristics, prognostic factors, and feasibility of ICI continuation in immune checkpoint inhibitor-related pneumonitis

open access: yesCancer Immunology, Immunotherapy
Purpose Immune checkpoint inhibitor (ICI)-related pneumonitis (ICI-pneumonitis) is a serious complication, whose clinical course and optimal management strategies remain inadequately elucidated.
Keisuke Masumoto   +7 more
doaj   +1 more source

Immune Checkpoint Inhibitor-Related Pneumonitis

open access: yes, 2021
Immune checkpoint inhibitors are novel agents that have been proved efficacious in a variety of cancer types, but they are associated with a unique set of organ-specific, immune-related adverse events.
Bouros, D.   +4 more
core   +1 more source

Esophagitis and Pneumonitis Related to Concurrent Chemoradiation ± Durvalumab Consolidation in Unresectable Stage III Non-Small-Cell Lung Cancer: Risk Assessment and Management Recommendations Based on a Modified Delphi Process

open access: yesCurrent Oncology
The addition of durvalumab consolidation to concurrent chemoradiation therapy (cCRT) has fundamentally changed the standard of care for patients with unresectable stage III non-small-cell lung cancer (NSCLC). Nevertheless, concerns related to esophagitis
Anthony M. Brade   +8 more
doaj   +1 more source

A case report of immune-related pneumonitis after combined treatment of non small cell lung cancer

open access: yesМедицинский совет, 2020
Immunotherapy is the most promising method in the treatment of lung cancer, especially in connection with the rapidly growing development of monoclonal antibodies aimed at inhibiting immune checkpoints: anti-CTLA-4, anti-PD-1, anti-PD-L1.
E. S. Denisova   +6 more
doaj   +1 more source

Pneumonitis and pneumonitis-related death in cancer patients treated with programmed cell death-1 inhibitors: a systematic review and meta-analysis

open access: yes, 2017
Peng-Fei Cui,1–3,* Jun-Xun Ma,1,* Fei-Xue Wang,1,* Jing Zhang,1 Hai-Tao Tao,1 Yi Hu1 1First Department of Medical Oncology, 2Department of Graduate Administration, Chinese PLA General Hospital, Beijing, 3Health Bureau of the 75709 Army, Central ...
Cui P   +5 more
core  

Hypersensitivity Pneumonitis

open access: yes, 2022
Hypersensitivity Pneumonitis, Jennifer Stalica, MD, Attending Pulmonologist, Divisions of Pulmonary Disease & Critical Care Medicine, Unity Pulmonary & Sleep ...
Stalica, Jennifer
core  

Pneumonitis Induced by Immune Checkpoint Inhibitors: From Clinical Data to Translational Investigation

open access: yesFrontiers in Oncology, 2020
Immune checkpoint inhibitors (ICIs) have been applied to clinical practice and achieved significant therapeutic benefit in a variety of human malignancies.
Shicong Zhu   +4 more
doaj   +1 more source

Aspiration Pneumonitis [PDF]

open access: yes, 2018
Aspiration pneumonitis is currently considered one of the major complications of anesthesia, with aspiration occurring in as many as 1 in every 2-3,000 surgical procedures (Nason, 2015).
Little, Meghan
core  

Nitrofurantoin Pneumonitis

open access: yes, 1977
A case of acute nitrofurantoin induced pneumonitis is reported. The various pulmonary toxicities of nitrofurantoin are also discussed.
Douglass J. Stennett   +2 more
core   +1 more source

Home - About - Disclaimer - Privacy